|
Real-time
Boerse Muenchen
10:13:34 2024-10-31 EDT
|
5-day change | 1st Jan Change | ||
| 2.180 EUR | +21.79% |
|
-.--% | - |
Company Valuation: TFF Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 |
|---|---|
| Market Cap 1 | 17.05 |
| Change | - |
| Enterprise Value (EV) 1 | 11.68 |
| Change | - |
| P/E | -0.61x |
| PBR | 1.79x |
| PEG | 0x |
| Capitalization / Revenue | 23,228,288x |
| EV / Revenue | - |
| EV / EBITDA | - |
| EV / EBIT | -0.53x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | -11.85 |
| Distribution rate | - |
| Net sales | 0.7339 |
| EBITDA | -21.39 |
| EBIT 1 | -21.89 |
| Net income 1 | -21.24 |
| Net Debt 1 | -5.363 |
| Reference price 2 | 7.207 |
| Nbr of stocks (in thousands) | 2,365 |
| Announcement Date | 3/28/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 10.9M | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 39.05B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 0K30 Stock
- Valuation TFF Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
